In PTEN mutated GBM, uninhibited Akt signaling leads to recruitment of the PD-L1 transcript to active polysomes for translation, leading to increased PD-L1 protein expression, which can be reversed with rapamycin, an mTOR inhibitor (61). The gene discussed is PTEN; the disease is glioblastoma.